Upfront Cost Guidance Limited in US Guidelines - Top-Institutions - MDSpire

Upfront Cost Guidance Limited in US Guidelines

Although most large US-based medical societies in a cross-sectional study explicitly suggested considering economic or resource use–related evidence during guideline development, only 3.8% of individual recommendations included that information in the recommendation statement itself.

  • By

  • Andrea Surnit

  • June 27, 2026

  • 6 min

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, CA

    Key Differentiators

    • Health Policy

  • #2

    Yale National Clinician Scholars Program
    Yale National Clinician Scholars Program

    New Haven, CT

    Key Differentiators

    • Health Policy

  • #3

    National Center for Advancing Translational Science
    National Center for Advancing Translational Science

    Bethesda, MD

    Key Differentiators

    • Health Policy

  • #4

    American Society of Clinical Oncology
    American Society of Clinical Oncology

    Alexandria, VA

    Key Differentiators

    • Health Policy

  • #5

    NYU Grossman School of Medicine
    NYU Grossman School of Medicine

    New York, NY

    Key Differentiators

    • Health Policy

Original Source(s)

Upfront Cost Guidance Limited in US Guidelines

  • by Andrea Surnit

  • June 27, 2026

Related Content

AI CAC Scoring Aids Workflow

A single-center editorial described real-world integration of artificial intelligence–based coronary artery calcium scoring into routine cardiac CT workflow, with researchers reporting rapid report availability and high agreement with manual reference standards while emphasizing continued radiologist oversight.

Remembering Past President Ido Weinberg, MD, MSc, MHA, FSVM (1976–2026)

Combo Therapy May Improve HbA1c in Type 2 Diabetes

Oral orforglipron could be more effective in reducing hemoglobin A1c and body weight, with no increased risk of hypoglycemia in patients with inadequately controlled type 2 diabetes.